These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16273362)

  • 1. New concepts of treatment strategies for hormone-related cancer. Proceedings of the 20th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. March 11-12, 2005. Nagoya, Japan.
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():1-99. PubMed ID: 16273362
    [No Abstract]   [Full Text] [Related]  

  • 2. New therapeutic strategies for higher cure rates: high dose therapy and new therapeutic modalities. Proceedings of the 12th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 4-5 October 1996.
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S1-118. PubMed ID: 9289398
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenges in Cancer Metastasis. Proceedings of the 14th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Nagoya, Japan, 11-12 September 1998.
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S1-103. PubMed ID: 10375280
    [No Abstract]   [Full Text] [Related]  

  • 4. State of the art for digestive organs. Proceedings of the 19th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. November 14-15, 2003. Nagoya, Japan.
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S1-90. PubMed ID: 15614933
    [No Abstract]   [Full Text] [Related]  

  • 5. The 11th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Cytokines and New Anticancer Agents on the Horizon of Oncology. Nagoya, Japan, 24-25 November 1995.
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S1-119. PubMed ID: 8777775
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings of the 5th International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Cambridge, Massachusetts, March 17-18, 2000.
    Mol Urol; 2000; 4(3):89-293; quiz 297-302. PubMed ID: 11184766
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings of the 1st International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Boston, Massachusetts, March 29-30, 1996.
    Urology; 1997 Mar; 49(3A Suppl):1-118; quiz 121-3. PubMed ID: 9123726
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings of the 3rd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer.
    Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-409S; quiz i-iv. PubMed ID: 14981797
    [No Abstract]   [Full Text] [Related]  

  • 9. Docetaxel (Taxotere): a new option for the treatment of hormone-refractory prostate cancer. Proceedings of a symposium. Chicago, Illinois, USA. April 23, 1999.
    Semin Oncol; 1999 Oct; 26(5 Suppl 17):1-68. PubMed ID: 10610580
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
    Come SE; Buzdar AU; Arteaga CL; Bissell MJ; Brown MA; Ellis MJ; Goss PE; Green JE; Ingle JN; Lee AV; Medina D; Nicholson RI; Santen RJ; Schiff R; Hart CS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-330S. PubMed ID: 14734487
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of breast cancer: a historical perspective.
    Hortobagyi GN
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-1-S17-4. PubMed ID: 9374083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary hormonal therapy.
    Smith DC
    Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Proceedings of the 5th International Conference, Cambridge, Massachusetts, USA, June 13-14, 2005.
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1068s. PubMed ID: 16541524
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings of the 2nd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Cambridge, Massachusetts, USA, June 28-29, 2002.
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):443S-532S; quiz i-vi. PubMed ID: 12838958
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
    Come SE; Buzdar AU; Ingle JN; Arteaga CL; Brown M; Dowsett M; Hilsenbeck SG; Kumar R; Johnston SR; Lee AV; Paik S; Pritchard KI; Winer EP; Hart C
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1000s. PubMed ID: 16467115
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings of the Nordic Ciba Cancer Care Workshop on Advanced Breast Cancer. Stockholm, 18-19 January 1996.
    Acta Oncol; 1996; 35 Suppl 5():1-102. PubMed ID: 9156525
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy and medical treatment of hepatocellular carcinoma (HCC).
    Rougier P; Mitry E; Clavero-Fabri MC
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1264-6. PubMed ID: 9730386
    [No Abstract]   [Full Text] [Related]  

  • 19. [New strategies of drugs for treatment of hormone-related tumors].
    von Angerer E
    Pharm Unserer Zeit; 1996 Apr; 25(2):74-84. PubMed ID: 8778815
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing concepts of hormone receptor-positive advanced breast cancer therapy.
    Chlebowski RT
    Clin Breast Cancer; 2013 Jun; 13(3):159-66. PubMed ID: 23228361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.